Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman(National Cancer Institute), Francis J. Giles(National University of Ireland), Douglas E. Gladstone(Northwell Health), Tanya Siddiqi(City Of Hope National Medical Center), Gail J. Roboz(Cornell University), Julio Delgado(Departament de Salut), Cecilia Arana Yi(Mayo Clinic Hospital), Giuseppe Saglio(University of Turin), Tamar Tadmor(Bnai Zion Medical Center), Lionel Karlin(Hôpital Lyon Sud), Kemal Balic(Serimmune (United States)), Ronan Swords(University of Miami), Gary J. Schiller(Fred Hutch Cancer Center), Philipp le Coutre(Humboldt-Universität zu Berlin), Michael Doubek(Central European Institute of Technology), Stéphane Leprêtre(Normandie Université), Frédéric Maloisel(European Union), Wyndham H. Wilson(National Institutes of Health), Philippe Rousselot(Université Paris-Saclay), Ira Pastan(National Institutes of Health), Bjørn Tore Gjertsen(Haukeland University Hospital), Sascha Dietrich(European Molecular Biology Organization), Dimitri Breems(Ziekenhuisnetwerk Antwerpen Stuivenberg), Claire Dearden(Royal Marsden Hospital), Andrzej Hellmann(Gdańsk Medical University), Mathias Rummel(Universitätsklinikum Gießen und Marburg), Shira Dinner(Dana-Farber Cancer Institute), Krimo Bouabdallah(Centre Hospitalier Universitaire de Bordeaux), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Larry Bacon(St. James's Hospital), Mirjana Gotić(Centar za Promociju Nauke), Marco Gobbi(Istituto di Ematologia di Bologna), Nathan Standifer(Serimmune (United States)), Xavier Troussard(Centre Hospitalier Universitaire de Caen Normandie), Tadeusz Robak(Medical University of Lodz), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Peng He, Nai-Shun Yao, Shannon Marshall, Fritz Offner(Ghent University Hospital), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Loree Larratt(University of Alberta), Monica Bocchia(University of Siena)
Cited by 250
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k